Lester Murray Antman Dba Simply Rich Janux Therapeutics, Inc. Transaction History
Lester Murray Antman Dba Simply Rich
- $350 Million
- Q4 2024
A detailed history of Lester Murray Antman Dba Simply Rich transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Lester Murray Antman Dba Simply Rich holds 24,315 shares of JANX stock, worth $765,922. This represents 0.37% of its overall portfolio holdings.
Number of Shares
24,315
Previous 7,964
205.31%
Holding current value
$765,922
Previous $361,000
260.39%
% of portfolio
0.37%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
229Shares Held
55.2MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$327 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$112 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$111 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$96.4 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$73.8 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.31B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...